We are live on
!
Find out more
Wealth Enhancement Advisory Services Portfolio holdings
AUM
$59.8B
1-Year Est. Return
29.42%
This Fund
S&P 500
This Quarter
Est. Return
+2.55%
1 Year Est. Return
+29.42%
3 Year Est. Return
+77.06%
5 Year Est. Return
+66.38%
10 Year Est. Return
+178.95%
AUM
$73.7B
AUM Growth
+$7.59B
(+11%)
Cap. Flow
+$5.52B
Cap. Flow
% of AUM
7.49%
Top 10 Holdings %
Top 10 Hldgs %
25.26%
Holding
3,840
New
264
Increased
2,051
Reduced
1,186
Closed
193
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$2.53B |
| 2 |
Lam Research
LRCX
|
+$252M |
| 3 |
ALPS Smith Core Plus Bond ETF
SMTH
|
+$161M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$151M |
| 5 |
BRIF
FIS Bright Portfolios Focused Equity ETF
BRIF
|
+$96.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Accenture
ACN
|
+$127M |
| 2 |
Schwab US Dividend Equity ETF
SCHD
|
+$106M |
| 3 |
Mastercard
MA
|
+$104M |
| 4 |
Janus Henderson AAA CLO ETF
JAAA
|
+$79.8M |
| 5 |
JPMorgan Ultra-Short Income ETF
JPST
|
+$70.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.15% |
| 2 | Financials | 6.29% |
| 3 | Industrials | 4.43% |
| 4 | Healthcare | 4.03% |
| 5 | Consumer Discretionary | 3.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3526
CPI Aerostructures
CVU
$70.4M
| $55.8K | ﹤0.01% |
13,350
| – | – |
|
3527
Sensus Healthcare
SRTS
$50.4M
| $53.9K | ﹤0.01% |
12,078
| – | – |
|
|
ITRG
3528
Integra Resources
ITRG
$519M
| $52.9K | ﹤0.01% |
12,933
+20
| +0.2% | +$67 |
|
3529
Larimar Therapeutics
LRMR
$437M
| $52.6K | ﹤0.01% |
15,614
-2,634
| -14% | -$10.2K |
|
|
DHY
3530
Credit Suisse High Yield Credit Fund
DHY
$240M
| $52K | ﹤0.01% |
25,886
+292
| +1% | +$597 |
|
|
OGI
3531
Organigram Holdings
OGI
$139M
| $49.1K | ﹤0.01% |
29,395
+50
| +0.2% | +$86 |
|
3532
OFG Bancorp
OFG
$2.21B
| $48.5K | ﹤0.01% |
1,152
-91
| -7% | -$3.73K |
|
3533
ARKO Corp
ARKO
$571M
| $46.4K | ﹤0.01% |
+10,472
| New | +$47K |
|
3534
Coty
COTY
$2.42B
| $46.4K | ﹤0.01% |
14,634
-997
| -6% | -$3.62K |
|
3535
Coherus Oncology
CHRS
$199M
| $45.8K | ﹤0.01% |
33,708
+5,322
| +19% | +$7.75K |
|
3536
ADC Therapeutics
ADCT
$142M
| $41.5K | ﹤0.01% |
11,722
+125
| +1% | +$507 |
|
3537
Andersons Inc
ANDE
$2.23B
| $41.1K | ﹤0.01% |
962
+246
| +34% | +$12K |
|
3538
ALX Oncology
ALXO
$293M
| $41K | ﹤0.01% |
37,992
-81
| -0.2% | -$123 |
|
3539
Pacific Biosciences
PACB
$360M
| $40.2K | ﹤0.01% |
19,337
+1,620
| +9% | +$3.11K |
|
3540
Gain Therapeutics
GANX
$75.9M
| $39.7K | ﹤0.01% |
15,556
| – | – |
|
3541
SKYX Platforms
SKYX
$165M
| $39.3K | ﹤0.01% |
16,596
+261
| +2% | +$466 |
|
3542
Hain Celestial
HAIN
$54.9M
| $37.8K | ﹤0.01% |
34,335
-6,783
| -16% | -$8.37K |
|
3543
BioLife Solutions
BLFS
$1.69B
| $37.5K | ﹤0.01% |
837
-71
| -8% | -$1.86K |
|
3544
Solitario Resources
XPL
$69.2M
| $37K | ﹤0.01% |
52,000
| – | – |
|
3545
Fate Therapeutics
FATE
$326M
| $35.3K | ﹤0.01% |
34,925
-3,818
| -10% | -$4.58K |
|
3546
Cineverse
CNVS
$67.7M
| $34.7K | ﹤0.01% |
16,225
| – | – |
|
3547
Claros Mortgage Trust
CMTG
$257M
| $33.7K | ﹤0.01% |
11,622
+698
| +6% | +$2.28K |
|
|
SLSN
3548
Solesence Inc
SLSN
$77.7M
| $33.7K | ﹤0.01% |
22,023
-5
| -0% | -$14 |
|
3549
Rafael Holdings
RFL
$101M
| $33.6K | ﹤0.01% |
26,479
+5,005
| +23% | +$6.49K |
|
|
NPKI
3550
NPK International
NPKI
$1.16B
| $32.9K | ﹤0.01% |
3,080
+118
| +4% | +$1.44K |
|
Similar funds
QCM
NAMI
Wealth Enhancement Advisory Services's Q4 2025 Portfolio in Review
As of Q4 2025, Wealth Enhancement Advisory Services held 3,840 positions worth $73.7B, up 11% from $66.1B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Wealth Enhancement Advisory Services deployed $5.52B of net new capital in Q4 2025, opening 264 new positions and adding to 2,051 existing holdings. Its largest new stake was FIS Bright Portfolios Focused Equity ETF: 3,197,675 shares worth $97.2M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 13% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Accenture, an estimated $127M trimmed.
- Wealth Enhancement Advisory Services's largest Q4 2025 buy was FIS Bright Portfolios Focused Equity ETF: 3,197,675 shares worth $97.2M.
- Wealth Enhancement Advisory Services added most to Broadcom in Q4 2025, an estimated $2.53B increase.
- Wealth Enhancement Advisory Services's biggest Q4 2025 reduction was Accenture, cutting an estimated $127M.
- Wealth Enhancement Advisory Services fully exited iShares iBonds Dec 2025 Term Treasury ETF in Q4 2025, selling an estimated $13.2M.
- Wealth Enhancement Advisory Services's ten largest holdings make up 25% of its $73.7B portfolio in Q4 2025.
- Wealth Enhancement Advisory Services opened 264 new positions and closed 193 in Q4 2025.
- Wealth Enhancement Advisory Services's portfolio value rose 11% quarter-over-quarter to $73.7B.
Based on Wealth Enhancement Advisory Services's 13F filing for Q4 2025, filed 8 Jan 2026.